Sort
8,912 grants matching “sars cov 2”
Resolving SARS-Cov-2 tropism and COVID19 pathology in the brain
$339,000Nadejda Mincheva Tsankova · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
NYU Pediatric Obesity, Metabolism and Kidney Cohort Center
$339,000Leonardo Trasande · New York University School Of Medicine · UH3 · FY2020 · OD
Entry and pathogenesis of two human coronaviruses
$338,636Thomas Miller Gallagher · University Of Iowa · P01 · FY2011 · AI
Assessing the determinants of durable protective immunity in SARS-CoV-2 infected human subjects
$338,565Stefan H.i. Kappe · Seattle Children'S Hospital · U01 · FY2020 · AI
UofU Maternal-Fetal Medicine Units (MFMU) Network: Clinical Centers
$338,536Torri D Metz · University Of Utah · UG1 · FY2023 · HD
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$338,254Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Early and long term immunity following SARS-CoV-2 infection in humans
$338,133William Messer · Oregon Health & Science University · R01 · FY2020 · AI
Comparison of defined live biotherapeutic product and fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection
$338,000Jeremiah James Faith · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK
Comparison of defined live biotherapeutic product and fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection
$338,000Jeremiah James Faith · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK
Role of anti-SARS-CoV T cell response in pathogenesis
$337,768Stanley Perlman · University Of Iowa · P01 · FY2015 · AI
CD4 T cell, germinal center, and antibody response defects in recurrent tonsillitis
$337,500Shane P Crotty · La Jolla Institute For Immunology · R01 · FY2022 · AI
Ubiquitin Regulation of K Channels in Health and Disease
$337,499Henry M Colecraft · Columbia University Health Sciences · R01 · FY2020 · HL
Genetic Approaches To Understanding Organ Development and Function
$337,442Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Role of anti-SARS-CoV T cell response in pathogenesis
$337,404Stanley Perlman · University Of Iowa · P01 · FY2012 · AI
CORE 3 : Modeling Core
$336,905Trey Ideker · University Of California, San Francisco · U19 · FY2023 · AI
Next-generation alchemical free energy methods and quantum/machine-learning models for drug discovery
$336,881Darrin M. York · Rutgers, The State Univ Of N.J. · R01 · FY2023 · GM
Clonal hematopoiesis and severity of COVID-19 disease
$336,624Kenneth Walsh · University Of Virginia · R21 · FY2021 · AG
Entry and pathogenesis of two human coronaviruses
$336,502Thomas Miller Gallagher · University Of Iowa · P01 · FY2015 · AI
Small Molecule Screening to Identify Novel Sars-CoV-2 Therapeutics
$336,020Sara Cherry · University Of Pennsylvania · R01 · FY2020 · AI
Long-term consequences of SARS-CoV-2 infection and COVID-19 disease among American Indians: an ambidirectional cohort study in the Cherokee Nation
$335,797Katrin Gaardbo Kuhn · Cherokee Nation · S06 · FY2022 · GM
Technology and Computational Core
$335,760Alexandra-Chloe Villani · Brigham And Women'S Hospital · P01 · FY2023 · AI
Preclinical studies to establish the combination of apoA-I mimetic peptides and statins as novel therapy for COVID-19
$335,400Theodoros Kelesidis · University Of California Los Angeles · R01 · FY2021 · AG
Entry and pathogenesis of two human coronaviruses
$335,229Thomas Miller Gallagher · University Of Iowa · P01 · FY2014 · AI
Patterns of immune response in COVID-19 patients
$335,156Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Entry and pathogenesis of two human coronaviruses
$334,983Thomas Miller Gallagher · University Of Iowa · P01 · FY2013 · AI